Evaluation report - Neuromodulatory drugs for cough

29th Nov 2017
The new evaluation report on neuromodulatory drug for cough is now online. This review aims to give objective information and guidance on efficacy, adverse effects, place in treatment and arrangements for prescribing to commissioners of health services, prescribers and others.
 
Please note that these documents are restricted to stakeholders only for a period of 3 months following publication.